GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93020C00048EVELIQURE BIOTECHNOLOGIES GMBH

Overview

Award facts

Net obligations
$11.48M
$11,480,630of $25.62M potential value
Outlays (paid to date)
$7.39M
$7.39M paid of $11.48M obligated$7,386,749
Period of performance
Sep 1, 2020 to Mar 31, 2027
Ends in 4 months
Modifications
18
Latest action Mar 31, 2026
Contract type
Definitive contract
PIID 75N93020C00048

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.

Dates and value

Award date
Signed on Aug 27, 2020
Current value
$11,480,630Base and exercised options
Potential value (if all options are exercised)
$25,619,524

Obligations by fiscal year of action

  • FY2025: $4,683,173
  • FY2024: $198,329
  • FY2023: $3,490,104
  • FY2022: $1,649,387
  • FY2021: $1,244,544
  • FY2020: $215,093

Total across 6 fiscal years: $11,480,630

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 31, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationWIEN, AUT
UEIZKEJW1JEKBQ9
CAGE code6311N
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org

Business types and certifications

For-profit organizationInternational organizationLimited liability company

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Austria

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
4

Solicitation and notices

Solicitation ID
HHS-NIH-NIAID-2019-1(as reported)
Solicitation date
Feb 22, 2019

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 27, 2020Base obligation at award: $215,093
Latest action
Mar 31, 2026 — Other administrative actionModification P00018; administrative: no change in scope or value
Latest substantive action
Sep 30, 2025 — Option exercisedModification P00016; obligation change +$721,600
Latest funding action
Sep 23, 2025 — Funding onlyModification P00015; obligation change -$2,618; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action11
  • Option exercised4
  • Funding only3
19 actions recorded, Aug 27, 2020 to Mar 31, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
AustriaAUT
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
19

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2020-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression